Degui Lin

697 total citations
25 papers, 538 citations indexed

About

Degui Lin is a scholar working on Molecular Biology, Oncology and Small Animals. According to data from OpenAlex, Degui Lin has authored 25 papers receiving a total of 538 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 8 papers in Oncology and 6 papers in Small Animals. Recurrent topics in Degui Lin's work include Cancer Cells and Metastasis (6 papers), Infectious Diseases and Mycology (6 papers) and Veterinary Oncology Research (5 papers). Degui Lin is often cited by papers focused on Cancer Cells and Metastasis (6 papers), Infectious Diseases and Mycology (6 papers) and Veterinary Oncology Research (5 papers). Degui Lin collaborates with scholars based in China, United States and Hong Kong. Degui Lin's co-authors include Yipeng Jin, Di Zhang, Huihao Xu, Jiahao Lin, Yingjie Zhang, Yibin Deng, Kai Fan, Lei Wang, Ji Wang and Huanan Wang and has published in prestigious journals such as PLoS ONE, Oncogene and Frontiers in Immunology.

In The Last Decade

Degui Lin

24 papers receiving 533 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Degui Lin China 13 239 113 101 100 85 25 538
Diego Carlos dos Reis Brazil 14 199 0.8× 120 1.1× 85 0.8× 29 0.3× 51 0.6× 38 491
Marina Pacheco Miguel Brazil 12 148 0.6× 44 0.4× 93 0.9× 69 0.7× 89 1.0× 50 587
Nadja Zöller Germany 18 199 0.8× 58 0.5× 44 0.4× 47 0.5× 77 0.9× 42 688
Karol Pawłowski Poland 17 263 1.1× 199 1.8× 209 2.1× 91 0.9× 33 0.4× 41 663
Poramate Klanrit Thailand 16 260 1.1× 61 0.5× 121 1.2× 101 1.0× 33 0.4× 62 670
Kirsty M. McLaughlin United Kingdom 13 476 2.0× 72 0.6× 198 2.0× 63 0.6× 114 1.3× 16 731
Ying‐Wai Lam United States 15 299 1.3× 81 0.7× 23 0.2× 27 0.3× 46 0.5× 32 639
Shanhu Li China 13 244 1.0× 57 0.5× 68 0.7× 59 0.6× 13 0.2× 37 423
Kohta Kurohane Japan 16 251 1.1× 177 1.6× 43 0.4× 81 0.8× 119 1.4× 53 863
Radek Fedr Czechia 13 351 1.5× 105 0.9× 147 1.5× 57 0.6× 14 0.2× 36 591

Countries citing papers authored by Degui Lin

Since Specialization
Citations

This map shows the geographic impact of Degui Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Degui Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Degui Lin more than expected).

Fields of papers citing papers by Degui Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Degui Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Degui Lin. The network helps show where Degui Lin may publish in the future.

Co-authorship network of co-authors of Degui Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Degui Lin. A scholar is included among the top collaborators of Degui Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Degui Lin. Degui Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
4.
Zhao, Fangying, et al.. (2022). Establishment of stable expression of firefly luciferase and EGFP in a canine inflammatory mammary carcinoma cell line and tumor-bearing model in nude mice. Frontiers in Veterinary Science. 9. 935005–935005. 3 indexed citations
5.
Gao, Jiafeng, Jingwen Cui, Yongqiang Wang, et al.. (2022). Tumor-associated macrophages in tumor progression and the role of traditional Chinese medicine in regulating TAMs to enhance antitumor effects. Frontiers in Immunology. 13. 1026898–1026898. 21 indexed citations
6.
Zhao, Ying, Nan Cheng, Di Zhang, et al.. (2021). Auranofin and ICG-001 Emerge Synergistic Anti-tumor Effect on Canine Breast Cancer by Inducing Apoptosis via Mitochondrial Pathway. Frontiers in Veterinary Science. 8. 772687–772687. 3 indexed citations
7.
Gao, Jiafeng, Yi-Nan Zhang, Jingwen Cui, et al.. (2021). A Polysaccharide From the Whole Plant of Plantago asiatica L. Enhances the Antitumor Activity of Dendritic Cell-Based Immunotherapy Against Breast Cancer. Frontiers in Pharmacology. 12. 678865–678865. 22 indexed citations
8.
Cui, Jingwen, Yipeng Jin, Huihao Xu, et al.. (2021). Research Progress on the Mechanism of the Acupuncture Regulating Neuro-Endocrine-Immune Network System. Veterinary Sciences. 8(8). 149–149. 34 indexed citations
9.
Cheng, Nan, Jiafeng Gao, Ying Zhao, et al.. (2020). Benzyl Isothiocyanate Induces Apoptosis and Inhibits Tumor Growth in Canine Mammary Carcinoma via Downregulation of the Cyclin B1/Cdk1 Pathway. Frontiers in Veterinary Science. 7. 580530–580530. 8 indexed citations
10.
Lang, Yue, Mengdong Wang, Chao Qin, et al.. (2020). Bclaf1 is a direct target of HIF-1 and critically regulates the stability of HIF-1α under hypoxia. Oncogene. 39(13). 2807–2818. 20 indexed citations
11.
Li, Peiran, Gaoxiang Chen, Xiaomei Zhang, et al.. (2019). Oncolytic activity of canine distemper virus in canine mammary tubular adenocarcinoma cells. Veterinary and Comparative Oncology. 17(2). 174–183. 11 indexed citations
12.
Cheng, Nan, Ying Zhao, Huihao Xu, et al.. (2019). Ivermectin inhibits canine mammary tumor growth by regulating cell cycle progression and WNT signaling. BMC Veterinary Research. 15(1). 276–276. 31 indexed citations
13.
Gao, Jiafeng, Kai Fan, Yipeng Jin, et al.. (2019). PEGylated lipid bilayer coated mesoporous silica nanoparticles co-delivery of paclitaxel and curcumin leads to increased tumor site drug accumulation and reduced tumor burden. European Journal of Pharmaceutical Sciences. 140. 105070–105070. 49 indexed citations
14.
Zhang, Hong, Lixin Jia, Yu‐Jing Yuan, et al.. (2017). Proteus mirabilis inhibits cancer growth and pulmonary metastasis in a mouse breast cancer model. PLoS ONE. 12(12). e0188960–e0188960. 16 indexed citations
15.
Zhou, Bin, et al.. (2017). Salinomycin inhibits canine mammary carcinoma in vitro by targeting cancer stem cells. Oncology Letters. 14(1). 427–432. 9 indexed citations
16.
Lin, Jiahao, Qiang Cai, Yanjun Xu, et al.. (2017). PEGylated Lipid bilayer coated mesoporous silica nanoparticles for co-delivery of paclitaxel and curcumin: Design, characterization and its cytotoxic effect. International Journal of Pharmaceutics. 536(1). 272–282. 68 indexed citations
17.
Wang, Huanan, Lei Wang, Yingjie Zhang, et al.. (2016). Inhibition of glycolytic enzyme hexokinase II (HK2) suppresses lung tumor growth. Cancer Cell International. 16(1). 9–9. 84 indexed citations
18.
Zhang, Di, et al.. (2015). The potential role of COX-2 in cancer stem cell-mediated canine mammary tumor initiation: an immunohistochemical study. Journal of Veterinary Science. 16(2). 225–225. 10 indexed citations
19.
Lin, Degui, et al.. (2008). Expression and significance of PTEN and VEGF in canine mammary gland tumours. Veterinary Research Communications. 32(6). 463–472. 44 indexed citations
20.
Qiu, Changwei, Degui Lin, Jinqiu Wang, & Lei Wang. (2007). Expression and significance of PTEN in canine mammary gland tumours. Research in Veterinary Science. 85(2). 383–388. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026